On September 30, 2017, the European Union’s sugar quota system will be abolished to allow greater market orientation among European sugar producers. The sugar quota system was established in 1968 to set a price floor, production limits, and import limits to insulate European sugar producers and end-users from price volatility on the global sugar market. With the abolishment next month, sugar producers will be able to ramp up production and exports, resulting in a variety of implications for downstream industries. Continue reading
Diabetes has long been an epidemic, but with increasing prevalence and rising cost, solving for the condition is now more pressing than ever. Patient empowerment and self-care have been deemed the keys to effective diabetes management, however gaps in education and ability exist. Developers—big and small—are buying into the self-care idea and are using digital to deliver on this vision. There are four primary pillars to diabetes management: blood glucose monitoring, diet, physical activity, and insulin delivery. Most hype has been dedicated to the revolutionary “artificial pancreas,” or closed-loop insulin delivery system, which automates insulin therapy. Yet, in most other aspects of diabetes management (e.g. physical activity and nutrition, which also apply to diabetics not dependent on insulin therapy), the patient cannot be fully taken out of the equation. Still, innovation is reshaping all four primary aspects of diabetes management, and while solutions other than the “artificial pancreas” still require human intervention, they do address some aspects of the feedback loop, ultimately equipping the patient with the education and means to self-manage their own condition. Our analysis reveals that select solutions – for example, genetics and microbiome-based food recommendation engines – hold an especially big promise, as they address multiple aspects of the feedback loop and come at a reasonable price. Readers should look to invest in high-value solutions that come at a reasonable price while approaching solutions that provide a fairly small value-to-price ratio with caution. In cases where a solution is lacking, readers should look to marry two or more existing solutions deemed complementary by the “flow of data in diabetes feedback loops” framework, which we establish by building on Lux’s IoT system data flow framework.
By: Noa Ghersin
What do bananas, citrus, coffee, and cocoa have in common? A few things actually, all of these crops are huge contributors to the global agriculture, food, and beverage industries, they are primarily grown in developing countries, each crop faces impending threats of disease and environmental stress, and all of these crops could learn a few things from the papaya.
Farmers have always selectively bred their crops for the most desirable and hearty traits. This process used to take years even decades to yield genetically superior fruits and vegetables, but now just when the technology and the need have reached a tipping point – the tide of public opinion has squelched the ability of farmers and geneticists to save their crops.
What can other crops learn from Papaya? Continue reading
Biometrics are gaining in popularity, from the standardization of fingerprint sensors in smartphones, to use of facial recognition in airports. While the hype today is in those two markets, there is still a lot of interest and activity in other spaces including the health sector. In the health sector, biometrics add new valuable use cases including improving identification of the patient, which leads to better access control, better clinical trial studies, and improved medication adherence. Below we go into depth of these three use cases to show the value of biometrics in the health space. Continue reading
Telehealth regulation has become a trending topic since U.S. legislators introduced the Medicare Telehealth Parity Act of 2017, but internationally, governments are taking mixed positions on regulation. Telehealth has grown in the past decade into a global industry that extends care across borders, and is driving innovation in areas like triage and disease management. Yet despite its proliferation, national policy remains disjointed and poses a major hurdle across the industry. Continue reading
Earlier this week, healthcare IT firm Change Healthcare became the newest member of the Hashed Health Blockchain Consortium, a distributed ledger consortium whose goal is to advance the use of blockchain protocols in healthcare. The expansion of this group and the quest for the establishment of standards for implementation of blockchain in healthcare are not surprising – the last year has witnessed a sharp uptick in developers looking to bring blockchain to the industry. However, while the number of companies starting to apply blockchain – a distributed ledger technology that claims to offer several benefits over traditional databases, such as improved trustworthiness and automated smart contracts – to healthcare is growing, and while there certainly is a lot of hype surrounding this activity, there still remains confusion on the specific challenges these companies are looking to tackle and on the value they promise to deliver. In the table below, we synthesize currently sought-after use cases for blockchain in health, outline tech developers’ claims, and highlight players in each solution category.
Reducing and substituting for sucrose has been the heartache of food and beverage companies for the past few decades. There are many products trying to do what sugar does, but landing slightly left of ideal, at best. Sugar possesses unique properties in combination that are difficult to replicate with just one product. We have grouped sugar substitutes into categories of origin. Each replacement category includes a variety of options for sweeteners and comes with its own advantages and disadvantages. Continue reading
From its headquarters in Shenzhen China, the HAX Accelerator has built a name for itself investing in early-stage hardware startups. Ever since the establishment of the partnership with Johnson and Johnson Innovation, HAX has been rapidly expanding its consumer health portfolio. Since then, Lux has spoken with seven consumer health-focused HAX graduates, which together represent a third of the accelerator’s investments in this segment since 2015. Below, we visualized these companies on the Lux Innovation Grid (LIG), highlighting the technology value and business execution of each player.
Biopesticides are en vogue in the world of agtech. Ever since Bayer acquired Agraquest for nearly half a billion dollars in 2012, start-ups have been raising significant money and jockeying for position as attractive partners and/or acquisition targets. The biopesticide market is still small – in the single-digit billions of dollars worldwide (see the Lux Research webinar “Planting Seeds for Future Success“) – but these products continue to take market share from the conventional pesticide market, which is worth more than $50 billion worldwide. While smaller companies like Marrone Bio Innovations and Stockton Agrimor have made headlines by developing promising biologicals, it’s really the world’s leading agrichemical companies that dominate the patent landscape for biopesticides (see figure below). Of the top 10 patent assignes in the biopesticide space, only five major companies and two smaller companies (Marrone and Qingdao Haolite) are represented. Notably absent from this group is Syngenta, a major player in the conventional agrichemical space.